News
Filter
-
Putting patient wellbeing and collaboration at the heart of what we do
-
Rethinking drug research, before it’s too late
-
MRC Technology, UCB and the University of Leicester combine research excellence and expertise to evolve drug discovery
-
New collaboration to explore novel treatments for respiratory diseases
-
MRC Technology monetises royalties on cancer drug Keytruda® (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital
-
MRC Technology and Keio University to collaborate on drug discovery
-
Patent protection for biotech/genetic engineering: report
-
Enhancing patient benefit from research spending: MRC Technology and DEBRA Austria sign agreement
-
Keytruda receives another breakthrough designation
-
MRC Technology completes move to Stevenage open innovation campus
-
MRC Technology appoints two new members to board of trustees
-
MRC Technology and Institut Pasteur of Shanghai, Chinese Academy of Sciences collaborate on antibody drug development
